Trial Profile
Influenza vaccination in old age: Immunological and biogerontological characterization of responders and non-responders.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms FLU-MARK
- 25 Jul 2015 Status changed from recruiting to discontinued as per European Clinical Trials Database record.
- 09 Nov 2011 New trial record